MRKR
Marker Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.18
+0.00%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.12
- Revenue estimate
- $2.1M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.09
- EPS estimate
- -$0.25
- Revenue actual
- —
- Revenue estimate
- $694.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +59.2%
- Revenue beats (12Q)
- 7
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.25 | -$0.09 | Beat 64.00% | — |
| May 15, 2026 | -$0.18 | -$0.16 | Beat 11.11% | — |
| Mar 18, 2026 | -$0.19 | -$0.04 | Beat 79.03% | $1.1M |
| Nov 13, 2025 | -$0.69 | -$0.12 | Beat 82.61% | $1.2M |
| Aug 14, 2025 | -$0.55 | -$0.29 | Beat 47.27% | $861.2K |
| May 21, 2025 | -$0.66 | -$0.27 | Beat 59.09% | $349.1K |
| Mar 31, 2025 | -$0.37 | -$0.42 | Miss -13.51% | $2.3M |
| Nov 14, 2024 | -$0.39 | -$0.26 | Beat 33.33% | $1.9M |
| Aug 14, 2024 | -$0.43 | -$0.25 | Beat 41.86% | $1.2M |
| May 15, 2024 | -$0.25 | -$0.27 | Miss -8.00% | $1.2M |
| Nov 9, 2023 | -$0.90 | -$0.34 | Beat 62.22% | $257.6K |
| Aug 14, 2023 | -$0.80 | -$0.47 | Beat 41.25% | $762.7K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026